3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
11
Glioblastoma
11
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
9
Oropharyngeal Neoplasms
7
Rectal Neoplasms
6
Neoplasms
6
Lung Neoplasms
6
Astrocytoma
6
Squamous Cell Carcinoma of Head and Neck
5
Burkitt Lymphoma
5
Urinary Bladder Neoplasms
4
Carcinoma
4
Adenocarcinoma of Lung
4
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Laryngeal Neoplasms
3
Hodgkin Disease
3
Gliosarcoma
3
Glioma
3
Esophageal Neoplasms
3
Adenocarcinoma Of Esophagus
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Interventions
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Bevacizumab
2
regorafenib
1
neratinib
1
lutetium Lu 177 dotatate
1
gallium Ga 68 dotatate
1
capivasertib
1
cabozantinib
1
brigatinib
1
abemaciclib
1
Watchful Waiting
1
Tablets
1
Surveys and Questionnaires
1
Sunitinib
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Protons
1
Proton Therapy
1
Observation
1
Nivolumab
1
Lysine
1
Ipilimumab
1
Hydroxyurea
1
HhAntag691
1
Ga(III)-DOTATOC
1
GSK2256098
1
Everolimus
1
CTLA-4 Antigen
1
Arginine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningioma
×
Radiotherapy
×
30 days
×
Clear all
No trials found.